Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
The National Comprehensive Cancer Network (NCCN) has signed a new agreement with Vietnam's K Hospital to expand locally adapted cancer care guidelines. Three new guideline adaptations — covering B-Cell Lymphomas, Hodgkin Lymphoma, and Thyroid Carcinoma — will join eight existing solid tumor guidelines already tailored for Vietnam. The move aims to bring evidence-based, resource-aware oncology care to clinicians across the country.
The National Comprehensive Cancer Network (NCCN) has signed a new agreement with the Viet Nam National Cancer Hospital (K Hospital) and the Vietnam Cancer Association (VCA), expanding a longstanding partnership to improve cancer care in Vietnam. The deal adds three new NCCN Guidelines Adaptations for Vietnam — B-Cell Lymphomas, Hodgkin Lymphoma, and Thyroid Carcinoma — marking the collaboration's first foray into hematologic malignancies.
These adapted guidelines are tailored to reflect Vietnam's available resources, clinical practice patterns, and regulatory environment, using a color-coded system to distinguish widely available options from more aspirational or cost-constrained alternatives. They complement Vietnam's national Ministry of Health guidelines and were developed with input from oncology experts across the country's northern, central, and southern regions.
Quick Facts:
Why it matters: Access to standardized, locally adapted oncology guidelines can meaningfully improve cancer outcomes in resource-variable settings. By expanding into blood cancers and thyroid carcinoma, NCCN and K Hospital are ensuring more Vietnamese patients and clinicians have access to globally informed, locally relevant cancer care.
